 Glen Rock, N.J., June 08, 2021 GLOBE NEWSWIRE -- RespireRx Pharmaceuticals Inc. OTCQB Market: RSPI RespireRx or the Company, a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling, is pleased to announce that the Companys senior management will participate in the following virtual investor conference in June 2021: 